Mesothelioma is a rare and aggressive form of cancer that primarily affects the mesothelium, the protective lining covering the lungs, abdominal cavity, and other organs. Most commonly linked to asbestos exposure, mesothelioma manifests in several forms, with pleural mesothelioma being the most prevalent type. The latency period between exposure and onset of symptoms can range from 20 to 50 years, complicating diagnosis and treatment options.

The most significant risk factor for developing mesothelioma is occupational exposure to asbestos, commonly found in industries such as construction, shipbuilding, and manufacturing. Additionally, secondary exposure through contact with asbestos particles on clothing or equipment poses a risk. Other potential risk factors include genetic predisposition, previous radiation therapy to the chest or abdomen, and certain uncommon environmental exposures.

Symptoms of mesothelioma often manifest insidiously and can include persistent cough, chest pain, shortness of breath, and fatigue. Patients may experience unexplained weight loss, abdominal swelling, or changes in bowel habits, depending on the affected site. Because these symptoms are common to many other conditions, mesothelioma diagnosis can be challenging and often occurs at an advanced stage.

Mesothelioma is primarily caused by exposure to asbestos, a naturally occurring mineral once widely used in construction and manufacturing. When asbestos fibers are inhaled or ingested, they can become lodged in the lining of the lungs, abdomen, or heart, leading to cellular damage and the potential development of cancerous tumors over time. Other factors, such as genetic predisposition and exposure to other carcinogens, may also contribute to the risk of developing mesothelioma, but asbestos remains the most significant risk factor.

Diagnosing mesothelioma typically involves a combination of imaging studies, such as X-rays or CT scans, followed by a biopsy to confirm the disease. Immunohistochemical staining can help differentiate mesothelioma from other types of tumors. Due to the complexity of the disease and its symptoms, a multidisciplinary approach is often employed, including input from oncologists, radiologists, and pathologists.

Treatment for mesothelioma typically involves a multimodal approach, including surgery, chemotherapy, and radiation therapy, depending on the stage and location of the cancer. Surgical options may involve the removal of the tumor and surrounding tissue, while chemotherapy and radiation can help to shrink tumors or control symptoms. Emerging therapies, such as immunotherapy and targeted therapy, are also being investigated and may offer new hope for patients with this aggressive cancer.

Preventing mesothelioma primarily involves mitigating exposure to asbestos, particularly in occupational settings where exposure risk is high. Regulatory measures, safe handling practices, and awareness campaigns are essential to protect workers and the general public. Individuals should also ensure proper management of buildings and materials known to contain asbestos, including seeking professional help for removal or remediation.